Quality of Life Issues in Pediatric Immune-Mediated Inflammatory Disease

被引:3
|
作者
Duffy, Ciaran M. [1 ,2 ,3 ]
Wells, George A.
Russell, Anthony S.
Haraoui, Boulos
机构
[1] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, CHEO Res Inst, Ottawa, ON K1H 8L1, Canada
[3] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8L1, Canada
关键词
QUALITY OF LIFE; OUTCOME ASSESSMENT; JUVENILE RHEUMATOID ARTHRITIS; INFLAMMATORY BOWEL DISEASE; JUVENILE-IDIOPATHIC-ARTHRITIS; GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE SCALE; BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; CROHNS-DISEASE; MENTAL-HEALTH; CHILDREN; ADOLESCENTS;
D O I
10.3899/jrheum.110905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been well established that children with a chronic disease, including those with inflammatory bowel disease (IBD) and juvenile idiopathic arthritis (JIA), report lower health-related quality of life (HRQOL) as compared to their healthy peers. Over the past 20 years there has been a significant emphasis on the development of measures of function and HRQOL for application in JIA and pediatric IBD. Several of the instruments currently used to assess HRQOL in children with immune-mediated inflammatory diseases (IMID), including the Juvenile Arthritis Quality of Life Questionnaire (JAQQ) and IMPACT questionnaire for pediatric IBD, were developed and validated by Canadian-based research teams. This review describes several disease-specific and generic instruments used to assess QOL in children with IBD or JIA. It also provides an overview of findings from several outcomes studies that applied the described tools in assessing HRQOL in children and adolescents with these conditions. (J Rheumatol 2011:38:Suppl 88; 20-5; doi:10.3899/jrheum.110905)
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [41] Immune monitoring and treatment in immune-mediated inflammatory diseases
    van Wijk, Femke
    de Bruin, Marjolein
    Leavis, Helen
    Nierkens, Stefan
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [42] Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
    Rizzello, Fernando
    Olivieri, Ignazio
    Armuzzi, Alessandro
    Ayala, Fabio
    Bettoli, Vincenzo
    Bianchi, Luca
    Cimino, Luca
    Costanzo, Antonio
    Cristaudo, Antonio
    D'Angelo, Salvatore
    Daperno, Marco
    Fostini, Anna Chiara
    Galeazzi, Mauro
    Gilio, Michele
    Gionchetti, Paolo
    Gisondi, Paolo
    Lubrano, Ennio
    Marchesoni, Antonio
    Offidani, Annamaria
    Orlando, Ambrogio
    Pugliese, Daniela
    Salvarani, Carlo
    Scarpa, Raffaele
    Vecchi, Maurizio
    Girolomoni, Giampiero
    ADVANCES IN THERAPY, 2018, 35 (04) : 545 - 562
  • [43] Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
    Bezzio, Cristina
    Della Corte, Cristina
    Vernero, Marta
    Di Luna, Imma
    Manes, Gianpiero
    Saibeni, Simone
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [44] Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
    Jiang, Yan
    Jarr, Karolin
    Layton, Cosima
    Gardner, Christopher D.
    Ashouri, Judith E.
    Abreu, Maria T.
    Sinha, Sidhartha R.
    NUTRIENTS, 2021, 13 (03) : 1 - 17
  • [45] Quality of life complements traditional outcome measures in immune-mediated polyneuropathies
    Merkies, ISJ
    Schmitz, PIM
    van der Meché, FGA
    Samijn, JPA
    van Doorn, PA
    NEUROLOGY, 2002, 59 (01) : 84 - 91
  • [46] Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study
    Chamorro-de-Vega, Esther
    Calvo, Alberto
    Fernandez-Pacheco, Maria
    Hernandez-Muniesa, Belen
    Romero-Jimenez, Rosa
    Casado-Gomez, Araceli
    Ramirez, Esther
    Morell, Alberto
    Herrero, Nuria
    Ubeda, Barbara
    Ais-Larisgoitia, Arantza
    Lobato-Matilla, Elena
    Munoz, Alvaro
    Casado, Miguel angel
    Escudero-Vilaplana, Vicente
    FARMACIA HOSPITALARIA, 2024, 48 (06) : 265 - 271
  • [47] IDENTIFICATION OF DISEASE DIAGNOSTIC AND DISEASE ACTIVITY METABOLOMIC BIOMARKERS IN IMMUNE-MEDIATED INFLAMMATORY DISEASES
    Alonso, A.
    Tornero, J.
    Fernandez Nebro, A.
    Canete, J.
    Domenech, E.
    Gisbert, J. P.
    Ferrandiz, C.
    Fonseca, E.
    Garcia, V.
    Blanco, F.
    Rodriguez, J.
    Gratacos, J.
    Carreira, P.
    Julia, A.
    Tortosa, R.
    Lasanta, M. L.
    Correig, X.
    Marsal, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 134 - 134
  • [48] The risk of cancer in pediatric-onset immune-mediated inflammatory diseases - A nationwide study
    Ehrstrom, Andrea
    Jansson, Sabine
    Jorgensen, Marianne Horby
    Wewer, Vibeke
    Malham, Mikkel
    JOURNAL OF AUTOIMMUNITY, 2024, 149
  • [49] Psychiatric comorbidity in immune-mediated inflammatory diseases
    Marrie, Ruth Ann
    Bernstein, Charles N.
    WORLD PSYCHIATRY, 2021, 20 (02) : 298 - 299
  • [50] The role of platelets in immune-mediated inflammatory diseases
    Scherlinger, Marc
    Richez, Christophe
    Tsokos, George C. C.
    Boilard, Eric
    Blanco, Patrick
    NATURE REVIEWS IMMUNOLOGY, 2023, 23 (08) : 495 - 510